Eli Lilly & Co. (LLY), ImaginAb Enter T-Cell-Based Immuno-Oncology Therapy Research Collaboration

October 13, 2015 7:01 AM

Eli Lilly & Co. (NYSE: LLY) and ImaginAb Inc. are pleased to announce a preclinical research collaboration to study potential ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found